Comparative phenotypic analysis of the major fungal pathogens Candida parapsilosis and Candida albicans

Linda M Holland1, Markus S Schröder1, Siobhán A Turner1

  • 1School of Biomedical and Biomolecular Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

Plos Pathogens
|September 19, 2014
PubMed

Insights

This study investigates virulence factors in Candida parapsilosis, a key pathogen in neonates. Researchers identified shared and unique gene functions between C. parapsilosis and Candida albicans, revealing species-specific biofilm regulators.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Genetics

Background:

  • Candida parapsilosis is a significant fungal pathogen, especially in premature neonates.
  • Its virulence properties are less understood compared to Candida albicans.
  • Understanding genetic differences can improve treatment strategies.

Purpose of the Study:

  • To construct and characterize C. parapsilosis mutant strains with deleted genes.
  • To compare the functional roles of genes in C. parapsilosis and C. albicans.
  • To identify novel virulence factors and regulators in C. parapsilosis.

Main Methods:

  • Generated double-allele deletion strains for 100 target genes in C. parapsilosis.
  • Assessed phenotypes across >40 growth conditions, including antifungal drug presence.
  • Compared results with C. albicans deletion strains and analyzed biofilm transcription profiles.

Main Results:

  • Identified shared gene functions, such as Upc2 in azole resistance and CAP1 in oxidative stress response.
  • Discovered species-specific roles, e.g., Cph2 in hypoxic response for C. parapsilosis.
  • Found significant divergence in biofilm regulators, with seven transcription factors and one kinase essential for C. parapsilosis biofilms.

Conclusions:

  • Many C. parapsilosis and C. albicans genes share functions, particularly metabolic processes.
  • Biofilm regulation shows extensive divergence, with Cph2 and Bcr1 being major regulators in C. parapsilosis.
  • This research highlights species-specific targets for antifungal therapies.